Abstract
Background: It has been established that pyrazine derivatives, which have widespread bioactivities, can effectively treat cancer.
Objectives: In this study, we investigated the effects of 2-methoxy-5-(oxiran-2-ylmethyl) phenyl pyrazine-2- carboxylate (2-mOPP), a new pyrazine derivative, on proliferation, viability, and apoptosis induction in human leukemia K562 cells.
Methods: For this purpose, the K562 cells were treated with various concentrations (20-120 μM) of the 2-mOPP for 24-72 hours. Cell viability was determined by MTT growth inhibition assay. Apoptotic activity of 2-mOPP was investigated morphologically by Hoechst staining, cell surface expression assay of phosphatidylserine by Annexin-V/PI technique, as well as DNA fragmentation assay. The effect of 2-mOPP on the K562 cell cycle was studied by flow cytometry. To determine the impact of 2-mOPP on the expression of intrinsic apoptosis-related genes, Bcl2 (anti-apoptotic), Bax (pro-apoptotic), and Survivin genes expression levels were evaluated before and after treatment with 2-mOPP through Real-Time PCR analysis.
Results: The results revealed that 2-mOPP inhibited viability with IC50 of 25μM in 72 h. Morphological changes assessment by fluorescence microscopy, Annexin V/PI double staining by flow cytometry, and DNA ladders formation upon cell treatment with the 2-mOPP showed that this compound induces apoptosis at IC50 value. Cell cycle arrest was observed in the G0/G1 phase, and the sub-G1 cell population (the sign of apoptosis) increased in a time-dependent manner. Low expression levels of Bcl2 and Survivin in K562 cells were observed 24-72 h after treatment. Along with the down-regulation of Survivin and Bcl2, the expression of Bax was increased after treatment with 2-mOPP.
Conclusion: These findings demonstrate that the new pyrazine derivative plays a crucial role in blocking the proliferation of the leukemic cells by inducing cell cycle arrest and apoptosis.
Keywords: 2-mOPP, apoptosis, leukemia, Bcl2, survivin, K562 cell.
[http://dx.doi.org/10.1038/nrc1044] [PMID: 12671667]
[http://dx.doi.org/10.1053/j.seminoncol.2003.11.006] [PMID: 14970941]
[http://dx.doi.org/10.1097/00019052-199708000-00004] [PMID: 9266153]
[http://dx.doi.org/10.1080/01926230701320337] [PMID: 17562483]
[http://dx.doi.org/10.1038/sj.onc.1207116]
[http://dx.doi.org/10.1038/sj.cr.7290045] [PMID: 11032168]
[http://dx.doi.org/10.1155/2012/524308]
[http://dx.doi.org/10.1016/j.mam.2010.02.001] [PMID: 20153362]
[http://dx.doi.org/10.1016/j.biopha.2011.03.001] [PMID: 21565459]
[http://dx.doi.org/10.1023/A:1020502800208] [PMID: 10634212]
[http://dx.doi.org/10.1074/jbc.M010259200] [PMID: 11106668]
[PMID: 14559822]
[http://dx.doi.org/10.1016/0145-2126(79)90033-X] [PMID: 95026]
[http://dx.doi.org/10.1038/leu.2010.143] [PMID: 20574455]
[http://dx.doi.org/10.1186/1475-2867-13-117] [PMID: 24257075]
[http://dx.doi.org/10.1182/blood-2003-12-4111] [PMID: 14982876]
[http://dx.doi.org/10.1182/blood-2008-03-144790] [PMID: 18827185]
[http://dx.doi.org/10.1016/j.biocel.2007.04.016] [PMID: 17543571]
[http://dx.doi.org/10.1016/j.tiv.2010.06.015] [PMID: 20600797]
[http://dx.doi.org/10.1056/NEJMoa062867] [PMID: 17151364]
[http://dx.doi.org/10.1016/j.ejmech.2010.02.026] [PMID: 20207452]
[http://dx.doi.org/10.1080/87559129209540951]
[http://dx.doi.org/10.1081/CNV-120030218] [PMID: 15199612]
[http://dx.doi.org/10.2174/1389557511313110007] [PMID: 23544468]
[http://dx.doi.org/10.1021/jm00020a003] [PMID: 7562923]
[http://dx.doi.org/10.1016/j.ejps.2009.02.012] [PMID: 19491013]
[http://dx.doi.org/10.15171/bi.2019.25] [PMID: 31799156]
[http://dx.doi.org/10.1016/j.trim.2012.10.001] [PMID: 23063462]
[http://dx.doi.org/10.1016/0022-1759(83)90303-4] [PMID: 6606682]
[http://dx.doi.org/10.1016/j.taap.2020.115331] [PMID: 33171188]
[http://dx.doi.org/10.1016/0022-1759(91)90198-O] [PMID: 1710634]
[http://dx.doi.org/10.1016/j.leukres.2013.07.009] [PMID: 23876826]
[http://dx.doi.org/10.1016/j.tox.2012.05.024] [PMID: 22677887]
[http://dx.doi.org/10.1016/j.leukres.2010.01.030] [PMID: 20206383]
[http://dx.doi.org/10.1016/j.bmcl.2011.05.035] [PMID: 21640587]
[http://dx.doi.org/10.1016/j.bmc.2008.10.066] [PMID: 19013820]
[http://dx.doi.org/10.1080/15384047.2017.1310341] [PMID: 28358223]
[http://dx.doi.org/10.1158/0008-5472.CAN-06-0605] [PMID: 16778216]
[http://dx.doi.org/10.1158/1535-7163.MCT-04-0338] [PMID: 15827343]
[http://dx.doi.org/10.1111/j.1349-7006.2008.01038.x] [PMID: 19068089]
[http://dx.doi.org/10.1182/blood-2002-08-2543] [PMID: 12393500]
[http://dx.doi.org/10.1182/blood-2002-06-1768] [PMID: 12424198]
[http://dx.doi.org/10.3727/096504003108748429] [PMID: 12725531]
[http://dx.doi.org/10.1034/j.1600-0714.2000.290901.x]
[http://dx.doi.org/10.1016/0092-8674(93)90509-O] [PMID: 8358790]
[http://dx.doi.org/10.1038/348334a0] [PMID: 2250705]
[PMID: 8402648]
[PMID: 8261449]
[http://dx.doi.org/10.1002/j.1460-2075.1996.tb00788.x] [PMID: 8861942]
[http://dx.doi.org/10.1074/jbc.272.21.13829] [PMID: 9153240]
[http://dx.doi.org/10.1093/emboj/17.14.3878] [PMID: 9670005]
[http://dx.doi.org/10.1016/S1097-2765(00)80456-6] [PMID: 10198631]
[http://dx.doi.org/10.1083/jcb.139.5.1281] [PMID: 9382873]
[http://dx.doi.org/10.1016/j.febslet.2010.07.002] [PMID: 20621101]
[http://dx.doi.org/10.33549/physiolres.931064] [PMID: 17184147]
[http://dx.doi.org/10.1016/j.ejphar.2006.12.017] [PMID: 17291488]
[http://dx.doi.org/10.1016/j.leukres.2009.03.033] [PMID: 19394692]
[http://dx.doi.org/10.1074/jbc.273.14.7787] [PMID: 9525868]
[http://dx.doi.org/10.1038/70242] [PMID: 10587640]
[PMID: 9823313]
[http://dx.doi.org/10.1002/1097-0142(20010601)91:11<2026:AID-CNCR1228>3.0.CO;2-E] [PMID: 11391581]
[http://dx.doi.org/10.1002/1097-0215(20010320)95:2<92:AID-IJC1016>3.0.CO;2-9] [PMID: 11241318]
[http://dx.doi.org/10.1159/000070659] [PMID: 12743425]
[http://dx.doi.org/10.1038/sj.bjc.6600546] [PMID: 12373603]
[http://dx.doi.org/10.1038/sj.bjc.6600696] [PMID: 12556969]
[PMID: 11668517]
[http://dx.doi.org/10.1016/S0140-6736(02)07990-4] [PMID: 11918915]
[http://dx.doi.org/10.1200/JCO.2002.20.4.1063] [PMID: 11844831]
[http://dx.doi.org/10.5858/2003-127-826-SIG] [PMID: 12823036]
[PMID: 9581817]
[http://dx.doi.org/10.1002/1097-0142(20010715)92:2<271:AID-CNCR1319>3.0.CO;2-0] [PMID: 11466679]
[http://dx.doi.org/10.1097/00019606-200203000-00007] [PMID: 11854600]
[http://dx.doi.org/10.3892/ijo.15.1.137] [PMID: 10375606]
![Wayfinder Image](/images/wayfinder.jpg)